Treatment
Dexamethasone clinical trials
We’re tracking 395 recruiting studies that include Dexamethasone, each written for real people, not researchers, below.
Recruiting studies
- NCT06262893Recruiting
Comparing nerve blocks for shoulder surgery
This study compares two types of nerve blocks for pain relief during shoulder surgery. It tests whether adding a common steroid (dexamethasone) to one block improves pain control.
AsyutAges 18–75 - NCT06356571RecruitingPhase 2
Isatuximab with carfilzomib and dexamethasone for multiple myeloma
This trial tests a new combination of drugs (isatuximab, carfilzomib, and dexamethasone) given as shots under the skin for people whose multiple myeloma has come back or stopped responding to treatment. It aims to see if this mix works better than previous options.
Phoenix, ArizonaAges 18 years+ - NCT07537660RecruitingPhase 2
Ear Stimulation and Steroids for Chemotherapy Nausea
This trial tests whether stimulating specific points on your ear, combined with a steroid medication, can reduce nausea and vomiting caused by two chemotherapy drugs (gemcitabine and paclitaxel) used to treat pancreatic cancer. The goal is to help you tolerate chemotherapy better.
HangzhouAges 18–85 - NCT07335887RecruitingPhase 2
Sonrotoclax and dexamethasone with or without daratumumab for AL amyloidosis with t(11;14)
This trial tests a new drug combination for people with a specific type of AL amyloidosis (light chain amyloidosis) that has a genetic marker called t(11;14). The treatment includes Sonrotoclax (a targeted therapy) plus steroids, and possibly another drug called daratumumab, to see if it can help control the disease.
BeijingAges 18 years+ - NCT07716189RecruitingPhase 3
Ear Acupuncture plus Dexamethasone for Nausea from Trastuzumab Deruxtecan
This trial tests if adding ear acupuncture to a standard anti-nausea medicine (dexamethasone) works better for nausea and vomiting caused by the breast cancer drug trastuzumab deruxtecan. The goal is to help you feel better during treatment.
HangzhouAges 18–85 - NCT07224672RecruitingPhase 2
Study of a drug combo for newly diagnosed AL amyloidosis
This trial tests a combination of four drugs (belantamab mafodotin, cyclophosphamide, bortezomib, and dexamethasone) for people newly diagnosed with AL amyloidosis who cannot have a stem cell transplant. The goal is to see if this combination is safe and effective at stopping the abnormal proteins from damaging your organs.
Rochester, MinnesotaAges 18 years+ - NCT03523221RecruitingPhase 1
Dexamethasone to prevent a second anaphylaxis reaction
This trial tests whether a dose of dexamethasone (a steroid medicine) can help stop anaphylaxis symptoms from returning after the first episode. It focuses on children with mild to moderate anaphylaxis in the emergency department.
DohaAges 3 months–14 years - NCT04061512RecruitingPhase 2/Phase 3
Rituximab plus ibrutinib versus standard steroids plus rituximab
This trial compares two starting treatment plans for Waldenström’s macroglobulinaemia, testing whether one works better or causes fewer problems. It studies rituximab plus ibrutinib versus a standard mix of rituximab, cyclophosphamide, and dexamethasone (steroids).
BathAges 18 years+ - NCT04240054RecruitingPhase 2
Study drugs before transplant for myeloma with kidney problems
This Phase 2 trial tests whether a combination of anti-myeloma medicines given before stem cell transplant works well and is safe for people with multiple myeloma who also have kidney problems. It may help control the myeloma and prepare you for the transplant.
Milwaukee, WisconsinAges 18 years+ - NCT04341155RecruitingPhase 2
Dexamethasone treatment for brain toxoplasmosis in people with HIV
This Phase 2 trial studies whether dexamethasone (a strong anti-inflammatory steroid) helps treat brain toxoplasmosis in adults with HIV. It looks at people who have symptoms and brain scan findings that fit cerebral toxoplasmosis and who have not already taken dexamethasone for more than a few days.
Bandung, West JavaAges 18 years+ - NCT04414475RecruitingPhase 2
Selinexor plus low-dose steroid for hard-to-treat myeloma
This Phase 2 trial tests selinexor (a targeted anti-cancer medicine) plus low-dose dexamethasone to treat multiple myeloma that has not responded to many prior treatments. It compares selinexor combinations depending on what medicines you’ve already had, aiming to reduce myeloma activity and improve outcomes.
Pátrai, AchaiaAges 18 years+ - NCT04508790RecruitingPhase 2
Leflunomide plus pomalidomide with dexamethasone for relapsed myeloma
This trial studies whether a combination of three medicines (leflunomide, pomalidomide, and dexamethasone) can better treat multiple myeloma that has come back or stopped responding. It may help people who are not good candidates for transplant and who have measurable disease.
Duarte, CaliforniaAges 18 years+ - NCT04513639RecruitingPhase 2/Phase 3
Checking treatment for multiple myeloma after MRD becomes negative
This study looks at whether people with newly diagnosed multiple myeloma can safely continue or adjust treatment after they reach “MRD-negative,” meaning very low signs of disease in the bone marrow. It may help reduce the chance of relapse while avoiding unnecessary treatment for some patients.
ÅlesundAges 18–75 - NCT04545242RecruitingPhase 4
Dexamethasone for severe lung failure from infections on ventilators
This trial studies whether dexamethasone (a steroid medicine) improves outcomes in adults who have sudden, severe breathing failure caused by an infection while they are on a breathing machine. It may help reduce inflammation in the lungs during critical illness.
Terrassa, BarcelonaAges 18 years+ - NCT04559425Recruiting
Registry study for immune-related serious slowed fetal heart rhythm
This study follows pregnancies where the baby has a serious immune-related heart rhythm problem (high-grade AV block). It collects information to better understand what happens during pregnancy and after delivery, especially when blood tests show anti-Ro/La antibodies.
Phoenix, ArizonaAges 16–50 - NCT04776395RecruitingPhase 2
Iberdomide to treat intermediate or high-risk smoldering myeloma
This Phase 2 study tests iberdomide alone or with low-dose dexamethasone in people with intermediate- or high-risk “smoldering” multiple myeloma. The goal is to see if the treatment can control or delay progression to active myeloma.
Atlanta, GeorgiaAges 18 years+ - NCT04862468RecruitingPhase 2
Dexamethasone after clot removal to calm leg swelling
This Phase 2 study tests whether a steroid medicine called dexamethasone can reduce inflammation after a clot (DVT) is removed in the thigh/behind-knee veins. If it works, it may help improve recovery and reduce ongoing leg problems after the procedure.
Orange, CaliforniaAges 18–89 - NCT04891289RecruitingPhase 2
Gemcitabine and oxaliplatin with a chemotherapy pump for bile duct cancer
This Phase 2 study tests gemcitabine plus oxaliplatin chemotherapy, and whether adding a chemotherapy pump (with floxuridine and dexamethasone) delivered to the liver improves outcomes. It is for people whose intrahepatic cholangiocarcinoma cannot be removed with surgery.
Bethesda, MarylandAges 18 years+ - NCT04915248RecruitingPhase 2
Study of daratumumab, bortezomib, and dexamethasone for plasmablastic lymphoma
This trial tests how well a combination of daratumumab, bortezomib, and dexamethasone works in people with plasmablastic lymphoma that has returned or did not respond to prior treatment. It aims to shrink measurable tumors and improve outcomes, including for some people living with HIV.
AnconaAges 18 years+ - NCT05120076RecruitingPhase 3
Dexamethasone during surgery to reduce hip surgery pain and nausea
This trial tests whether a single steroid medicine called dexamethasone given around the time of surgery can reduce pain and nausea after a periacetabular osteotomy. It may help you feel more comfortable in the first days after surgery, depending on your medical history.
ZurichAges 18–99 - NCT05208307RecruitingPhase 2
Belantamab with pomalidomide and dexamethasone after high-risk myeloma transplant
This Phase 2 study tests a treatment combination (belantamab mafodotin, pomalidomide, and dexamethasone) for high-risk multiple myeloma after an autologous stem cell transplant. It aims to improve disease control in people who have certain genetic features or aggressive disease behavior.
Atlanta, GeorgiaAges 18 years+ - NCT05272826RecruitingPhase 2
New, untreated myeloma study using four medicines
This Phase 2 trial tests a combination of medicines (iberdomide, bortezomib, dexamethasone, and adding isatuximab) for people with newly diagnosed multiple myeloma who cannot have a transplant. The goal is to improve disease control while checking safety in older adults who can take pills and attend frequent visits.
Edmonton, AlbertaAges 65 years+ - NCT05319730RecruitingPhase 1/Phase 2
Testing new drugs, with or without pembrolizumab, for advanced esophageal cancer
This trial studies investigational cancer medicines, either alone or along with pembrolizumab, for people with advanced esophageal squamous cell cancer whose cancer has grown despite prior immune and platinum-based treatment. It may offer a new option after standard therapy has not worked.
Tucson, ArizonaAges 18 years+ - NCT05522465RecruitingPhase 4
Steroid treatment for children with ITP to raise platelets
This trial studies a short, high-dose steroid plan (prednisone plus dexamethasone) to treat immune thrombocytopenia (ITP) in children and raise low platelet counts. It may help reduce bleeding risk while using an approach tested in children soon after diagnosis.
Fujian, FujianAges 4 weeks–14 years
Common questions
- Are there clinical trials studying Dexamethasone?
- Yes. Clin2 currently lists 395 recruiting studies that include Dexamethasone, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Dexamethasone trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Dexamethasone an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Dexamethasone or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.